Leading global law firm Baker McKenzie advised global investment platform Mérieux Equity Partners (MxEP) on its €40 million investment into Swixx. In addition, HBM Healthcare Investments (HBM) of Zug, Switzerland, who had invested in Swixx in 2017, will co-invest alongside Mérieux, increasing HBM’s investment in Swixx by €5 million.

The new capital will be used to leverage the steady growth that Swixx has enjoyed over the past few years. The company operates fully owned subsidiaries across Central and Eastern Europe, Greece, and Russia. With 600 employees and sales exceeding EUR 260 million in 2021, Swixx is one of the largest and fastest-growing dedicated commercialization platform for biopharma and self-medication innovative companies in Central Eastern Europe.

“We are delighted to partner with Swixx’s management team, founders and HBM,” said Benoît Chastaing, Managing Partner at MxEP. “We look forward to support the company in its next development phase. We have been impressed by how quickly Swixx has established itself as a reputable partner for biopharma clients based upon the highest standards of professionalism, knowledge and service. Mérieux aims to deploy its own expertise and industrial network to support Swixx’s future growth.”

“It is a great pleasure to welcome Mérieux Equity Partners,” commented Swixx co-founder Michael Seeley. “We are honoured that such a well-regarded healthcare fund as MxEP has seen fit to invest in Swixx. The Mérieux family’s long history of scientific innovation speaks for itself, and we feel privileged to be associated with such a partner. It’s my hope that Swixx, bolstered with this new infusion of €45 million cumulatively in growth capital, will be able to access even more new opportunities in acquisitions, licensing, and portfolio expansion. We look forward to work together with Benoît and his team.”

The Baker McKenzie team advising MxEP was led by Alexander Fischer (Zurich) and Stephane Davin (Paris) with support from Boris Wenger, Roger Thomi, Julia Schieber, Susanne Liebel-Kotz, Selina Many, Raphael Schneuwly and Eylem Kutay (all Zurich) and Guillaume Le Camus, François-Xavier Naime, Robin Gaulier, Charles Baudoin (all Paris).
Explore Our Newsroom